Health Law Alliance (“HLA”) is proud to announce another major victory in defending an independent community pharmacy against OptumRx (“Optum”)’s network termination. After Optum issued a formal termination notice, citing inventory discrepancies, alleged non-compliance with prior corrective actions, and other findings frequently raised in Pharmacy Benefits Manager (“PBM”) audits, the pharmacy retained HLA to challenge and overturn Optum’s decision. Through strategic advocacy, meticulous appeal submissions, and deep expertise in PBM enforcement and healthcare law, HLA successfully secured a full reversal of the termination.
This result highlights the critical importance of prompt, substantive, and legally grounded responses to PBM audit findings and network actions, and underscores the value of engaging experienced PBM attorneys who understand the complexities of PBM audits, pharmacy operations, and federal and state regulatory frameworks.
Termination Based on Common PBM Audit Allegations
Optum’s termination notice alleged several discrepancies, including inventory shortages and related issues, concerns that pharmacies nationwide increasingly face as PBMs intensify their audit activities. These adverse findings often serve as the basis for aggressive PBM enforcement that can trigger significant recoupments, immediate withholding of reimbursement, and network terminations, which leads to loss of access to critical patient populations, all of which can destabilize pharmacy operations overnight.
HLA’s Immediate and Comprehensive Legal Strategy
Upon being retained, HLA immediately assembled a comprehensive, legally grounded response. Our team addressed each alleged deficiency in detail, provided corrective action measures, and demonstrated operational improvements, presented extensive legal arguments establishing that termination was unwarranted, unsupported, and contrary to applicable federal and state laws. Moreover, HLA’s attorneys worked closely with pharmacy leadership to document a strong commitment to best practices, regulatory compliance, and ongoing audit-readiness.
After reviewing multiple detailed submissions from HLA, Optum reversed its termination decision, allowing the pharmacy to remain in-network and continue serving its patients and community.
Why Pharmacies Choose HLA for PBM Audit and Termination Defense
HLA brings unmatched experience to pharmacy–PBM disputes. Our PBM practice is led by attorneys with years of experience dealing directly with PBM audits, network terminations, as well contractual and regulatory compliance issues.
Our representation goes far beyond drafting an appeal letter. We guide pharmacies through comprehensive corrective strategies, documentation enhancement procedures, regulatory compliance, and operational changes PBMs often require for continued network participation.
When a pharmacy retains HLA, our team conducts a deep legal and factual review of the allegations and prepares a detailed, evidence-based response addressing each issue with precision. Our PBM attorneys collaborate closely with each client to prevent termination, reverse termination, or negotiate alternative corrective pathways that preserve network access, wherever possible.
Our approach is thorough, strategic, and rooted in a sophisticated understanding of PBM expectations, audit methodologies, and contractual enforcement mechanisms.
A Proven Track Record of Protecting Pharmacies
This Optum reinstatement is another example of HLA’s unwavering commitment to defending pharmacies against PBM overreach and protecting their ability to continue serving their patients. While no two PBM matters are identical, the principles remain constant: timeliness matters, documentation matters, and having the right legal team can mean the difference between business survival and closure.
How HLA Can Help
If your pharmacy is facing a PBM audit, recoupment demand, or network termination, you should not navigate the process alone. HLA stands ready to provide strategic guidance, aggressive advocacy, and experienced representation to protect your pharmacy and your patients.
To learn more about how HLA can assist your pharmacy, contact us today for a free legal consultation.
MORE ARTICLES BY CATEGORY
Ketamine Marketing Risks for Mental Health Providers
Ketamine marketing is under increasing regulatory scrutiny, with providers facing risk over claims, off-label promotion, and patient targeting. Even well-intentioned messaging can trigger audits or enforcement if it crosses compliance lines.
Read More >>Why PBMs are Investigating Provider-Patient Relationships—And What it Means for Your Pharmacy
PBMs are ramping up audit pressure in 2026, now targeting provider-patient relationships to justify recoupments and even network terminations. Without precise documentation, even well-established prescriptions can put pharmacies at serious financial and operational risk.
Read More >>HLA Wins Full Reversal of PBM Credentialing Denial for an Independent Pharmacy
This week, Health Law Alliance achieved full reversal of a PBM credentialing denial for a New York pharmacy—mere weeks after it received a termination notice. Read more to learn how Health Law Alliance’s tireless advocacy can help your pharmacy in credentialing disputes.
Read More >>From Prior Authorization to Network Termination: The PBM Audit Trend Independent Pharmacies Must Watch
PBMs are increasingly targeting pharmacies over their role in the prior authorization process, using vague allegations to justify massive recoupments and even terminations. Without airtight documentation and clear procedures, even compliant pharmacies can face serious financial and legal risk.
Read More >>
